CARsgen® U.S. Clinical Holds Lifted by FDA ...Middle East

PR Newswire - News
CARsgen® U.S. Clinical Holds Lifted by FDA
SHANGHAI, Oct. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the U.S. Food and Drug Administration ("FDA") lifted the...

Hence then, the article about carsgen u s clinical holds lifted by fda was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen® U.S. Clinical Holds Lifted by FDA )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
myMOTHERLODE - before 5 hours & 18 minute